Clinical Research Center of Reading LLP — Wyomissing, Pennsylvania

Clinical Research Center of Reading LLP is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Research Center of Reading LLP has participated in 14 clinical trials.

Therapeutic areas: Fibromyalgia, Rheumatoid Arthritis, Osteoarthritis.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Pfizer, Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wyomissing

Browse all research sites in Pennsylvania · View every site in Wyomissing

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research Center of Reading LLP?

Clinical Research Center of Reading LLP has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research Center of Reading LLP conducted?

Clinical Research Center of Reading LLP has 14 clinical trials on record. Their work covers Fibromyalgia, Rheumatoid Arthritis, Osteoarthritis.

Is Clinical Research Center of Reading LLP accredited by Crixeo Clinical Trials?

Clinical Research Center of Reading LLP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Research Center of Reading LLP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.